The mean platelet volume in subjects with impaired fasting glucose

被引:106
作者
Coban, E [1 ]
Bostan, F [1 ]
Ozdogan, M [1 ]
机构
[1] Akdeniz Univ, Fac Med, Dept Internal Med, TR-07070 Antalya, Turkey
关键词
cardiovascular risk; diabetes mellitus; impaired fasting glucose; mean platelet volume; platelet mass; platelet counts;
D O I
10.1080/09537100500220729
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Mean platelet volume (MPV), a determinant of platelet function, is a newly emerging risk factor for atherothrombosis. Impaired fasting glucose (IFG) is probably a frequent glycemic disorder in the general population and is considered as a prediabetic state. The present study was designed to evaluate MPV in subjects with IFG compared with diabetic patients and normoglycemic control subjects. We selected 50 patients with type 2 diabetes mellitus, 50 subjects with IFG, and 50 normoglycemic healthy subjects matched for age, gender, and body mass index. MPV was very significantly higher in diabetic and IFG groups than in control group (p < 0.00, p < 0.05, respectively); it was also higher in diabetic group than in IFG group (p < 0.05). Platelet counts were not different among the study groups (p > 0.05). Platelet mass was significantly higher in diabetic and IFG groups than in normotensives (p < 0.00, p < 0.05, respectively); and it was also higher in diabetic group than in IFG group (p < 0.05). MPV and platelet mass were positively correlated with fasting glucose and HbA1c in diabetic and IFG groups (p < 0.05). In conclusion, our data suggests one possible mechanism by which subjects with IFG may be at increased cardiovascular risk.
引用
收藏
页码:67 / 69
页数:3
相关论文
共 19 条
  • [1] Is there glycemic threshold for mortality risk?
    Balkau, B
    Bertrais, S
    Ducimetiere, P
    Eschwege, E
    [J]. DIABETES CARE, 1999, 22 (05) : 696 - 699
  • [2] Balkau B, 1999, DIABETES CARE, V22, P1667
  • [3] BATH PMW, 1994, J HUM HYPERTENS, V8, P457
  • [4] Fasting blood glucose: An underestimated risk factor for cardiovascular death - Results from a 22-year follow-up of healthy nondiabetic men
    Bjornholt, JV
    Erikssen, G
    Aaser, E
    Sandvik, L
    Nitter-Hauge, S
    Jervell, J
    Erikssen, J
    Thaulow, E
    [J]. DIABETES CARE, 1999, 22 (01) : 45 - 49
  • [5] Megakaryocyte ploidy and platelet changes in human diabetes and atherosclerosis
    Brown, AS
    Hong, Y
    deBelder, A
    Beacon, H
    Beeso, J
    Sherwood, R
    Edmonds, M
    Martin, JF
    Erusalimsky, JD
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (04) : 802 - 807
  • [6] Serum sialic acid, a possible cardiovascular risk factor is not increased in Fijan Melanesians with impaired glucose tolerance or impaired fasting glucose
    Crook, MA
    Goldsmith, L
    Ameerally, P
    Lumb, P
    Singh, N
    Miell, J
    Russell-Jones, D
    [J]. ANNALS OF CLINICAL BIOCHEMISTRY, 2002, 39 : 606 - 608
  • [7] Influence of aspirin on platelet count and volume in humans
    Erhart, S
    Beer, JH
    Reinhart, WH
    [J]. ACTA HAEMATOLOGICA, 1999, 101 (03) : 140 - 144
  • [8] Gavin JR, 1997, DIABETES CARE, V20, P1183
  • [9] Mean platelet volume in type 2 diabetic patients
    Hekimsoy, Z
    Payzin, B
    Örnek, T
    Kandogan, G
    [J]. JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2004, 18 (03) : 173 - 176
  • [10] Impaired fasting glucose, blood pressure and cardiovascular disease mortality
    Henry, P
    Thomas, F
    Benetos, A
    Guize, L
    [J]. HYPERTENSION, 2002, 40 (04) : 458 - 463